BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 19181614)

  • 21. Dehydrodiconiferyl alcohol, a lignan from Herpetospermum pedunculosum, alleviates cholestasis by activating pathways associated with the farnesoid X receptor.
    Wei X; Ma Y; Dong Z; Wang G; Lan X; Liao Z; Chen M
    Phytomedicine; 2021 Jan; 80():153378. PubMed ID: 33113499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ginsenosides Restore Lipid and Redox Homeostasis in Mice with Intrahepatic Cholestasis through SIRT1/AMPK Pathways.
    Li G; Xu Y; Gao Q; Guo S; Zu Y; Wang X; Wang C; Zhang C; Liu D
    Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Wedelolactone alleviates cholestatic liver injury by regulating FXR-bile acid-NF-κB/NRF2 axis to reduce bile acid accumulation and its subsequent inflammation and oxidative stress.
    Wang MQ; Zhang KH; Liu FL; Zhou R; Zeng Y; Chen AL; Yu Y; Xia Q; Zhu CC; Lin CZ
    Phytomedicine; 2024 Jan; 122():155124. PubMed ID: 38014837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nuclear factor-E2-related factor 2 is a major determinant of bile acid homeostasis in the liver and intestine.
    Weerachayaphorn J; Mennone A; Soroka CJ; Harry K; Hagey LR; Kensler TW; Boyer JL
    Am J Physiol Gastrointest Liver Physiol; 2012 May; 302(9):G925-36. PubMed ID: 22345550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Network pharmacology-based mechanism prediction and pharmacological validation of Xiaoyan Lidan formula on attenuating alpha-naphthylisothiocyanate induced cholestatic hepatic injury in rats.
    Wang M; Liu F; Yao Y; Zhang Q; Lu Z; Zhang R; Liu C; Lin C; Zhu C
    J Ethnopharmacol; 2021 Apr; 270():113816. PubMed ID: 33444723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deleterious effect of oltipraz on extrahepatic cholestasis in bile duct-ligated mice.
    Weerachayaphorn J; Luo Y; Mennone A; Soroka CJ; Harry K; Boyer JL
    J Hepatol; 2014 Jan; 60(1):160-6. PubMed ID: 23978715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Yinchenzhufu decoction protects against alpha-naphthylisothiocyanate-induced acute cholestatic liver injury in mice by ameliorating disordered bile acid homeostasis and inhibiting inflammatory responses.
    Wang GF; Li YY; Shi R; Wang TM; Li YF; Li WK; Zheng M; Fan FB; Zou J; Zan B; Wu JS; Ma YM
    J Ethnopharmacol; 2020 May; 254():112672. PubMed ID: 32084553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Target profiling analyses of bile acids in the evaluation of hepatoprotective effect of gentiopicroside on ANIT-induced cholestatic liver injury in mice.
    Tang X; Yang Q; Yang F; Gong J; Han H; Yang L; Wang Z
    J Ethnopharmacol; 2016 Dec; 194():63-71. PubMed ID: 27582267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minimal role of hepatic transporters in the hepatoprotection against LCA-induced intrahepatic cholestasis.
    Beilke LD; Besselsen DG; Cheng Q; Kulkarni S; Slitt AL; Cherrington NJ
    Toxicol Sci; 2008 Mar; 102(1):196-204. PubMed ID: 18032408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of andrographolide on intrahepatic cholestasis induced by alpha-naphthylisothiocyanate in rats.
    Khamphaya T; Chansela P; Piyachaturawat P; Suksamrarn A; Nathanson MH; Weerachayaphorn J
    Eur J Pharmacol; 2016 Oct; 789():254-264. PubMed ID: 27475677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Silymarin protects the liver from α-naphthylisothiocyanate-induced cholestasis by modulating the expression of genes involved in bile acid homeostasis.
    Sohail I; Malkani N; Tahir N; Khalil A; Attar R; Mumtaz S
    Cell Mol Biol (Noisy-le-grand); 2022 Jul; 68(7):208-212. PubMed ID: 36495494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between alpha-naphthylisothiocyanate-induced liver injury and elevations in hepatic non-protein sulfhydryl content.
    Dahm LJ; Bailie MB; Roth RA
    Biochem Pharmacol; 1991 Aug; 42(6):1189-94. PubMed ID: 1679630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection against alpha-naphthylisothiocyanate-induced liver injury by decreased hepatic non-protein sulfhydryl content.
    Dahm LJ; Roth RA
    Biochem Pharmacol; 1991 Aug; 42(6):1181-8. PubMed ID: 1679629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of ablation and activation of Nrf2 on bile acid homeostasis in male mice.
    Zhang Y; Lickteig AJ; Liu J; Csanaky IL; Klaassen CD
    Toxicol Appl Pharmacol; 2020 Sep; 403():115170. PubMed ID: 32738332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alisma orientale extract exerts the reversing cholestasis effect by activation of farnesoid X receptor.
    Huo XK; Liu J; Yu ZL; Wang YF; Wang C; Tian XG; Ning J; Feng L; Sun CP; Zhang BJ; Ma XC
    Phytomedicine; 2018 Mar; 42():34-42. PubMed ID: 29655695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Organic anion transporting polypeptide 1a1 null mice are sensitive to cholestatic liver injury.
    Zhang Y; Csanaky IL; Cheng X; Lehman-McKeeman LD; Klaassen CD
    Toxicol Sci; 2012 Jun; 127(2):451-62. PubMed ID: 22461449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective effect of herbal medicine Huangqi decoction against chronic cholestatic liver injury by inhibiting bile acid-stimulated inflammation in DDC-induced mice.
    Li WK; Wang GF; Wang TM; Li YY; Li YF; Lu XY; Wang YH; Zhang H; Liu P; Wu JS; Ma YM
    Phytomedicine; 2019 Sep; 62():152948. PubMed ID: 31129431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paeoniflorin ameliorates ANIT-induced cholestasis by activating Nrf2 through an PI3K/Akt-dependent pathway in rats.
    Chen Z; Ma X; Zhu Y; Zhao Y; Wang J; Li R; Chen C; Wei S; Jiao W; Zhang Y; Li J; Wang L; Wang R; Liu H; Shen H; Xiao X
    Phytother Res; 2015 Nov; 29(11):1768-75. PubMed ID: 26269092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholestatic potentials of alpha-naphthylisothiocyanate (ANIT) and beta-naphthylisothiocyanate (BNIT) in the isolated perfused rat liver.
    Kossor DC; Handler JA; Dulik DM; Meunier PC; Leonard TB; Goldstein RS
    Biochem Pharmacol; 1993 Dec; 46(11):2061-6. PubMed ID: 8267654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis.
    Zollner G; Fickert P; Silbert D; Fuchsbichler A; Marschall HU; Zatloukal K; Denk H; Trauner M
    J Hepatol; 2003 Jun; 38(6):717-27. PubMed ID: 12763363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.